Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

New developments in lipid management
New developments in lipid management
by pasty-toler
CGR 0800 h 11 May 2015. Rob Hegele MD FRCPC FACP....
Dr Kate Shipman Consultant Chemical Pathologist University Hospitals Sussex
Dr Kate Shipman Consultant Chemical Pathologist University Hospitals Sussex
by hadley
Familial Hypercholesterolaemia. 2. Learning Object...
An audit of non-HDL cholesterol reporting
An audit of non-HDL cholesterol reporting
by luanne-stotts
Rachel . Randle. Clinical Scientist in-service HS...
Biochemistry Mayur V. Patel
Biochemistry Mayur V. Patel
by eliza
Consultant in Chemical Pathology/Metabolic Medicin...
Is lower better? LDL targets and beyond.
Is lower better? LDL targets and beyond.
by olivia-moreira
Implications of the relationship between risk fac...
Is lower better? LDL targets and beyond.
Is lower better? LDL targets and beyond.
by trish-goza
Implications of the relationship between risk fac...
Lipid management
Lipid management
by phoebe-click
د. حسين محمد جمعة . اختصا...
CVD Fellowship QI Project Ideas – Further Information
CVD Fellowship QI Project Ideas – Further Information
by brooke
01. Project Ideas. 2. QI Project Ideas. 3. Familia...
Hyperlipidemia Done by: Mohannad A. AL-Shibani
Hyperlipidemia Done by: Mohannad A. AL-Shibani
by nicole
Pharm.D intern. 1. . Main points. Pathophsiology...
LIPOPROTEINS Because lipids are relatively insoluble in aqueous media,
LIPOPROTEINS Because lipids are relatively insoluble in aqueous media,
by deena
They bind with . soluble . protein. complexes . c...
13 Plasma lipids and lipoproteins
13 Plasma lipids and lipoproteins
by lauren
Plasma lipids . 200 . Lipoproteins . 201 . Fatty a...
The grey zone: What to do for the “intermediate risk” patient?
The grey zone: What to do for the “intermediate risk” patient?
by tatyana-admore
Lifestyle-Heart Hypothesis. Mozaffarian. et al. ...